Skip to main content
Premium Trial:

Request an Annual Quote

Richard Rew, Randall Myers

Luminex has appointed Richard Rew as SVP, general counsel and corporate secretary, effective March 4, and Randall Myers as SVP, global manufacturing and quality, effective March 16. 

Prior to joining Luminex, Rew served as SVP, general counsel, and secretary at ArthroCare, which was acquired by Smith & Nephew last year. Myers retired from Applied Materials in 2012 and has since served as a consultant on supply chain and manufacturing operations. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.